LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression

The development and progression of colorectal cancer (CRC) have been associated with genetic and epigenetic alterations and more recently with changes in cell metabolism. Amino acid transporters are key players in tumor development, and it is described that tumor cells upregulate some AA transporter...

Full description

Bibliographic Details
Main Authors: Francisca Dias, Cristina Almeida, Ana Luísa Teixeira, Mariana Morais, Rui Medeiros
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/2/195
_version_ 1827589168617750528
author Francisca Dias
Cristina Almeida
Ana Luísa Teixeira
Mariana Morais
Rui Medeiros
author_facet Francisca Dias
Cristina Almeida
Ana Luísa Teixeira
Mariana Morais
Rui Medeiros
author_sort Francisca Dias
collection DOAJ
description The development and progression of colorectal cancer (CRC) have been associated with genetic and epigenetic alterations and more recently with changes in cell metabolism. Amino acid transporters are key players in tumor development, and it is described that tumor cells upregulate some AA transporters in order to support the increased amino acid (AA) intake to sustain the tumor additional needs for tumor growth and proliferation through the activation of several signaling pathways. LAT1 and ASCT2 are two AA transporters involved in the regulation of the mTOR pathway that has been reported as upregulated in CRC. Some attempts have been made in order to develop therapeutic approaches to target these AA transporters, however none have reached the clinical setting so far. MiRNA-based therapies have been gaining increasing attention from pharmaceutical companies and now several miRNA-based drugs are currently in clinical trials with promising results. In this review we combine a bioinformatic approach with a literature review in order to identify a miRNA profile with the potential to target both LAT1 and ASCT2 with potential to be used as a therapeutic approach against CRC.
first_indexed 2024-03-09T00:50:46Z
format Article
id doaj.art-b0e62672128943b1a61d9b487d273c60
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T00:50:46Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-b0e62672128943b1a61d9b487d273c602023-12-11T17:14:00ZengMDPI AGBiomedicines2227-90592021-02-019219510.3390/biomedicines9020195LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer ProgressionFrancisca Dias0Cristina Almeida1Ana Luísa Teixeira2Mariana Morais3Rui Medeiros4Molecular Oncology and Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Research Center—LAB2, E Bdg 1st Floor, Rua Dr António Bernardino de Almeida, 4200-072 Porto, PortugalMolecular Oncology and Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Research Center—LAB2, E Bdg 1st Floor, Rua Dr António Bernardino de Almeida, 4200-072 Porto, PortugalMolecular Oncology and Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Research Center—LAB2, E Bdg 1st Floor, Rua Dr António Bernardino de Almeida, 4200-072 Porto, PortugalMolecular Oncology and Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Research Center—LAB2, E Bdg 1st Floor, Rua Dr António Bernardino de Almeida, 4200-072 Porto, PortugalMolecular Oncology and Viral Pathology Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Research Center—LAB2, E Bdg 1st Floor, Rua Dr António Bernardino de Almeida, 4200-072 Porto, PortugalThe development and progression of colorectal cancer (CRC) have been associated with genetic and epigenetic alterations and more recently with changes in cell metabolism. Amino acid transporters are key players in tumor development, and it is described that tumor cells upregulate some AA transporters in order to support the increased amino acid (AA) intake to sustain the tumor additional needs for tumor growth and proliferation through the activation of several signaling pathways. LAT1 and ASCT2 are two AA transporters involved in the regulation of the mTOR pathway that has been reported as upregulated in CRC. Some attempts have been made in order to develop therapeutic approaches to target these AA transporters, however none have reached the clinical setting so far. MiRNA-based therapies have been gaining increasing attention from pharmaceutical companies and now several miRNA-based drugs are currently in clinical trials with promising results. In this review we combine a bioinformatic approach with a literature review in order to identify a miRNA profile with the potential to target both LAT1 and ASCT2 with potential to be used as a therapeutic approach against CRC.https://www.mdpi.com/2227-9059/9/2/195colorectal canceramino acid transportersLAT1ASCT2miRNAs
spellingShingle Francisca Dias
Cristina Almeida
Ana Luísa Teixeira
Mariana Morais
Rui Medeiros
LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
Biomedicines
colorectal cancer
amino acid transporters
LAT1
ASCT2
miRNAs
title LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
title_full LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
title_fullStr LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
title_full_unstemmed LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
title_short LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
title_sort lat1 and asct2 related micrornas as potential new therapeutic agents against colorectal cancer progression
topic colorectal cancer
amino acid transporters
LAT1
ASCT2
miRNAs
url https://www.mdpi.com/2227-9059/9/2/195
work_keys_str_mv AT franciscadias lat1andasct2relatedmicrornasaspotentialnewtherapeuticagentsagainstcolorectalcancerprogression
AT cristinaalmeida lat1andasct2relatedmicrornasaspotentialnewtherapeuticagentsagainstcolorectalcancerprogression
AT analuisateixeira lat1andasct2relatedmicrornasaspotentialnewtherapeuticagentsagainstcolorectalcancerprogression
AT marianamorais lat1andasct2relatedmicrornasaspotentialnewtherapeuticagentsagainstcolorectalcancerprogression
AT ruimedeiros lat1andasct2relatedmicrornasaspotentialnewtherapeuticagentsagainstcolorectalcancerprogression